C12N 2760/16122
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/16122 (New viral proteins or individual genes, new structural or functional aspects of) appears on 869 US grants and 1,210 published applications in this corpus.
Search patents in C12N- Granted patents
- 869
- Published applications
- 1,210
- Assignees
- 574
- Inventors
- 2,084
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 12 | 0 |
| 1997 | 15 | 0 |
| 1998 | 24 | 0 |
| 1999 | 14 | 0 |
| 2000 | 20 | 0 |
| 2001 | 28 | 1 |
| 2002 | 16 | 14 |
| 2003 | 14 | 45 |
| 2004 | 14 | 34 |
| 2005 | 13 | 26 |
| 2006 | 8 | 31 |
| 2007 | 16 | 42 |
| 2008 | 22 | 36 |
| 2009 | 26 | 62 |
| 2010 | 23 | 80 |
| 2011 | 26 | 55 |
| 2012 | 29 | 49 |
| 2013 | 35 | 56 |
| 2014 | 49 | 64 |
| 2015 | 56 | 45 |
| 2016 | 46 | 55 |
| 2017 | 48 | 54 |
| 2018 | 45 | 50 |
| 2019 | 40 | 51 |
| 2020 | 37 | 38 |
| 2021 | 26 | 49 |
| 2022 | 29 | 58 |
| 2023 | 29 | 50 |
| 2024 | 35 | 79 |
| 2025 | 27 | 42 |
| 2026 | 18 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Virus-like particles containing CST1 protein and toxoplasma vaccine using same1 Sep 2026US 12,721,886 B2University-Industry Cooperation Group of Kyung Hee University
- Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)25 Aug 2026US 12,714,745 B2Baylor Research Institute
- Method for prevention and treatment of viral disease25 Aug 2026US 12,714,746 B2Morehouse School of Medicine
- Avian influenza vaccines and methods of making same28 Jul 2026US 12,691,170 B2The United States of America as represented by the Secretary of Agriculture
- Construction and application of recombinant H5N8 subtype avian influenza virus carrying mapple fluorescence reporter gene16 Jun 2026US 12,655,396 B2South China Agricultural University
- Influenza ehead immunogens1 Oct 2026US 2026/0295029 A1The Scripps Research Institute
- Universal avian flu vaccine (aiv)1 Oct 2026US 2026/0297137 A1DEI Biopharma
- Recombinant neuraminidase and uses thereof17 Sep 2026US 2026/0275315 A1Icahn School of Medicine at Mount Sinai
- Universal influenza mrna vaccine and use thereof10 Sep 2026US 2026/0263585 A1Shanghai Institute of Biological Products Co., Ltd.
- Influenza b virus mutants and uses therefor10 Sep 2026US 2026/0263586 A1FluGen, Inc.
Most cited
By later US patents
- Modified vaccinia virus298US 4,603,112 AHealth Research, Inc. · 1986
- Modified vaccinia virus and methods for making and using the same264US 4,769,330 AHealth Research, Inc. · 1988
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Method for immunizing animals with synthetically modified vaccinia virus240US 4,722,848 AHealth Research, Inc. · 1988
- Recombinant negative strand RNA virus expression-systems218US 5,166,057 AMount Sinai School of Medicine of the City University of New York · 1992